Company: Valeant's Zelapar for Parkinson's gets conditional FDA approval

10/5/2005 | TheStreet.com

The FDA granted Valeant Pharmaceuticals International conditional approval for its drug Zelapar, used for treating Parkinson's disease, the company said. The agency told the company it would need clarification of information it had previously supplied about the drug, which once before had received conditional approval when it was owned by Amarin. Valeant acquired the Amarin's U.S. unit last year.

View Full Article in:

TheStreet.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA